Publications

Kelly Bailey

Lopez-Nunez O, Cafferata B, Santi M, Ranganathan S, Pearce TM, Kulich SM, Bailey KM, Broniscer A, Rossi S, Zin A, Nasrallah MP, Li MM, Zhong Y, Miele E, Alaggio R, Surrey LF. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature. Brain Pathol. 2021 Jan;31(1):70-83. doi: 10.1111/bpa.12900. PubMed PMID: 32997853; PMCID: PMC8018079.
McAuley JR, Bailey KM, Ekambaram P, Klei LR, Kang H, Hu D, Freeman TJ, Concel VJ, Hubel NE, Lee JL, Klei HB, Cheng J, Sekar P, Bridwell RE, Covic L, Lucas PC, McAllister-Lucas LM. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types. Oncogene. 2019 Dec;38(49):7384-7398. doi: 10.1038/s41388-019-0958-4. PubMed PMID: 31420608.
Bailey KM, Julian CM, Klinghoffer AN, Bernard H, Lucas PC, McAllister-Lucas LM. EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosis. Oncotarget. 2019 May 21;10(36):3385-3399. doi: 10.18632/oncotarget.26939. PubMed PMID: 31164960; PMCID: PMC6534359.
Venier RE, Maurer LM, Kessler EM, Ranganathan S, McGough RL, Weiss KR, Malek MM, Meade J, Tersak JM, Bailey KM. A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counseling. Pediatr Blood Cancer. 2019 Sep;66(9):e27824. doi: 10.1002/pbc.27824. PubMed PMID: 31157509.
Bailey K, Cost C, Davis I, Glade-Bender J, Grohar P, Houghton P, Isakoff M, Stewart E, Laack N, Yustein J, Reed D, Janeway K, Gorlick R, Lessnick S, DuBois S, Hingorani P. Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force. F1000Res. 2019;8 doi: 10.12688/f1000research.18139.1. PubMed PMID: 31031965; PMCID: PMC6468706.
Bailey KM. Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma. Oncotarget. 2018 Dec 18;9(99):37270-37271. doi: 10.18632/oncotarget.26465. PubMed PMID: 30647860; PMCID: PMC6324671.
Bailey KM, Durham AB, Zhao L, Fullen D, Geiger J, Bradford C, Opipari V, Johnson T, Mody R. Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysis. Transl Pediatr. 2018 Jul;7(3):203-210. doi: 10.21037/tp.2018.01.03. PubMed PMID: 30159246; PMCID: PMC6087836.

<< Investigators Search

Top